Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Moore

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
JAMA Network Open|February 15, 2020
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical TrialDaniel V T Catenacci, Leah Chase, Samantha Lomnicki, et al.
JAMA Psychiatry|January 26, 2022
Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation: A Randomized Clinical TrialEdna B Foa, Helen Blair Simpson, Thea Gallagher, et al.
Behaviour Research and Therapy|June 5, 2021
Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorderHelen B Simpson, Edna B Foa, Michael G Wheaton, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
JAMA Network Open|February 15, 2020
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical TrialDaniel V T Catenacci, Leah Chase, Samantha Lomnicki, et al.
JAMA Psychiatry|January 26, 2022
Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation: A Randomized Clinical TrialEdna B Foa, Helen Blair Simpson, Thea Gallagher, et al.
Behaviour Research and Therapy|June 5, 2021
Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorderHelen B Simpson, Edna B Foa, Michael G Wheaton, et al.
Pageof 9